Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.
复制标题
DOI:
10.1002/mds.27326
复制
发表时间:
2018-05
期刊:
影响因子:
--
通讯作者:
Tansey MG
中科院分区:
文献类型:
--
作者:
Houser MC;Chang J;Factor SA;Molho ES;Zabetian CP;Hill-Burns EM;Payami H;Hertzberg VS;Tansey MG
Gastrointestinal symptoms are common in Parkinson’s disease and frequently precede the development of motor impairments. Intestinal inflammation has been proposed as a driver of disease pathology, and evaluation of inflammatory mediators in stool could possibly identify valuable early-stage biomarkers. We measured immune- and angiogenesis-related proteins in human stool to examine inflammatory profiles associated with Parkinson’s disease. Stool samples and subjects’ self-reported metadata were obtained from 156 individuals with Parkinson’s disease and 110 without, including spouse and non-household controls. Metadata were probed for disease-associated differences, and levels of 37 immune and angiogenesis factors in stool homogenates were measured by multiplexed immunoassay and compared across experimental groups. Parkinson’s disease patients reported greater incidence of intestinal disease and digestive problems than controls. Direct comparison of levels of stool analytes in patients and controls revealed elevated Flt1, IL-1α, and CXCL8 in patients’ stool. Paired comparison of patients and spouses suggested higher levels of multiple factors in patients, but this was complicated by sex differences. Sex, body mass index, a history of smoking, and use of probiotics were found to strongly influence levels of stool analytes. Multivariate analysis accounting for these and other potential confounders confirmed elevated levels of IL-1α and CXCL8 and additionally revealed increased IL-1β and CRP in stool in Parkinson’s disease. These differences were not dependent on subject age or disease duration. Levels of stool immune factors indicate that intestinal inflammation is present in patients with Parkinson’s disease.
登录
查看更多内容
影响因子:
4.9
作者:
Haep, Lisa;Britzen-Laurent, Nathalie;Stuerzl, Michael
通讯作者:
Stuerzl, Michael
影响因子:
3.4
作者:
Capaldo, Christopher T.;Nusrat, Asma
通讯作者:
Nusrat, Asma
影响因子:
12.6
作者:
Chen H;Zhao EJ;Zhang W;Lu Y;Liu R;Huang X;Ciesielski-Jones AJ;Justice MA;Cousins DS;Peddada S
通讯作者:
Peddada S
影响因子:
--
作者:
Chang, JW;Kim, CS;Lee, SK
通讯作者:
Lee, SK
影响因子:
3.7
作者:
Breckenridge CB;Berry C;Chang ET;Sielken RL Jr;Mandel JS
通讯作者:
Mandel JS